1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane affects expression EXP 6480464 o, p'-DDT affects the expression of PSMD2 mRNA CTD PMID:17984292 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane increases expression EXP 6480464 o, p'-DDT results in increased expression of PSMD2 mRNA CTD PMID:24096037 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane increases expression ISO RGD:1313973 6480464 o, p'-DDT results in increased expression of PSMD2 mRNA CTD PMID:24096037 1,2-dimethylhydrazine increases expression ISO RGD:1313973 6480464 1, 2-Dimethylhydrazine results in increased expression of PSMD2 mRNA CTD PMID:22206623 17alpha-ethynylestradiol multiple interactions ISO RGD:1313973 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PSMD2 mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of PSMD2 mRNA CTD PMID:24096037 17alpha-ethynylestradiol increases expression ISO RGD:1313973 6480464 Ethinyl Estradiol results in increased expression of PSMD2 mRNA CTD PMID:24096037 17beta-estradiol multiple interactions ISO RGD:1313972 6480464 [Estradiol co-treated with TGFB1 protein] results in increased expression of PSMD2 mRNA CTD PMID:30165855 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one multiple interactions ISO RGD:1313972 6480464 Metribolone promotes the reaction [NDRG1 protein binds to PSMD2 protein] CTD PMID:17220478 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one increases expression ISO RGD:1313972 6480464 Metribolone results in increased expression of PSMD2 protein CTD PMID:17152098 1H-pyrazole increases expression ISO RGD:1313973 6480464 pyrazole results in increased expression of PSMD2 mRNA CTD PMID:17945193 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO RGD:1313973 6480464 2 more ... CTD PMID:30294300 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1313973 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PSMD2 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1313972 6480464 Tetrachlorodibenzodioxin affects the expression of PSMD2 mRNA CTD PMID:22574217 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1313973 6480464 Tetrachlorodibenzodioxin affects the expression of PSMD2 mRNA CTD PMID:21570461 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of PSMD2 mRNA CTD PMID:21346803 2-hydroxypropanoic acid decreases expression ISO RGD:1313972 6480464 Lactic Acid results in decreased expression of PSMD2 mRNA CTD PMID:30851411 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1313972 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of PSMD2 mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol multiple interactions ISO RGD:1313972 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of PSMD2 mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol increases expression ISO RGD:1313972 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of PSMD2 protein CTD PMID:34186270 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of PSMD2 mRNA CTD PMID:36041667 aflatoxin B1 increases expression ISO RGD:1313972 6480464 Aflatoxin B1 results in increased expression of PSMD2 mRNA CTD PMID:22100608 aristolochic acid A increases expression ISO RGD:1313972 6480464 aristolochic acid I results in increased expression of PSMD2 mRNA CTD PMID:33212167 azoxystrobin decreases expression ISO RGD:1313972 6480464 azoxystrobin results in decreased expression of PSMD2 mRNA CTD PMID:33512557 Benoxacor decreases expression ISO RGD:1313973 6480464 benoxacor results in decreased expression of PSMD2 mRNA CTD PMID:34850242 benzo[a]pyrene increases methylation ISO RGD:1313972 6480464 Benzo(a)pyrene results in increased methylation of PSMD2 3' UTR, Benzo(a)pyrene results in increased methylation of PSMD2 promoter CTD PMID:27901495 benzo[a]pyrene affects methylation ISO RGD:1313972 6480464 Benzo(a)pyrene affects the methylation of PSMD2 exon CTD PMID:30157460 bis(2-ethylhexyl) phthalate increases expression EXP 6480464 Diethylhexyl Phthalate results in increased expression of PSMD2 mRNA CTD PMID:21318169 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of PSMD2 mRNA CTD PMID:25181051 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of PSMD2 mRNA CTD PMID:36041667 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of PSMD2 gene CTD PMID:28505145 bisphenol F multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of PSMD2 mRNA CTD PMID:36041667 cadmium atom multiple interactions ISO RGD:1313972 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PSMD2 mRNA CTD PMID:35301059 cadmium dichloride increases expression ISO RGD:1313973 6480464 Cadmium Chloride results in increased expression of PSMD2 mRNA CTD PMID:18974090 cadmium dichloride multiple interactions ISO RGD:1313972 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PSMD2 mRNA CTD PMID:35301059 caffeine decreases phosphorylation ISO RGD:1313972 6480464 Caffeine results in decreased phosphorylation of PSMD2 protein CTD PMID:35688186 cobalt dichloride increases expression ISO RGD:1313972 6480464 cobaltous chloride results in increased expression of PSMD2 mRNA CTD PMID:19320972 , PMID:19376846 copper(II) chloride increases expression ISO RGD:1313972 6480464 cupric chloride results in increased expression of PSMD2 mRNA CTD PMID:17211630 copper(II) sulfate increases expression ISO RGD:1313972 6480464 Copper Sulfate results in increased expression of PSMD2 mRNA CTD PMID:19549813 cyclosporin A increases expression ISO RGD:1313972 6480464 Cyclosporine results in increased expression of PSMD2 mRNA CTD PMID:20106945 , PMID:25562108 dexamethasone multiple interactions ISO RGD:1313972 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of PSMD2 mRNA CTD PMID:28628672 diclofenac increases expression ISO RGD:1313973 6480464 Diclofenac results in increased expression of PSMD2 mRNA CTD PMID:26934552 elesclomol increases expression ISO RGD:1313972 6480464 elesclomol results in increased expression of PSMD2 mRNA CTD PMID:18723479 enzyme inhibitor multiple interactions ISO RGD:1313972 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of PSMD2 protein CTD PMID:23301498 ethanol affects splicing ISO RGD:1313973 6480464 Ethanol affects the splicing of PSMD2 mRNA CTD PMID:30319688 finasteride increases expression EXP 6480464 Finasteride results in increased expression of PSMD2 mRNA CTD PMID:24136188 flutamide increases expression EXP 6480464 Flutamide results in increased expression of PSMD2 mRNA CTD PMID:24136188 indometacin multiple interactions ISO RGD:1313972 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of PSMD2 mRNA CTD PMID:28628672 isoprenaline multiple interactions EXP 6480464 [Isoproterenol co-treated with POSTN protein] results in decreased expression of PSMD2 mRNA CTD PMID:30303030 ivermectin decreases expression ISO RGD:1313972 6480464 Ivermectin results in decreased expression of PSMD2 protein CTD PMID:32959892 lead(0) decreases expression ISO RGD:1313972 6480464 Lead results in decreased expression of PSMD2 mRNA CTD PMID:19921347 lead(0) affects expression ISO RGD:1313972 6480464 Lead affects the expression of PSMD2 mRNA CTD PMID:28903495 lead(2+) decreases expression ISO RGD:1313972 6480464 Lead results in decreased expression of PSMD2 mRNA CTD PMID:19921347 lead(2+) affects expression ISO RGD:1313972 6480464 Lead affects the expression of PSMD2 mRNA CTD PMID:28903495 leflunomide increases expression EXP 6480464 leflunomide results in increased expression of PSMD2 mRNA CTD PMID:24136188 morphine multiple interactions EXP 6480464 Morphine deficiency inhibits the reaction [Morphine results in decreased expression of PSMD2 protein] CTD PMID:23056601 morphine decreases expression EXP 6480464 Morphine results in decreased expression of PSMD2 protein CTD PMID:23056601 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal increases expression ISO RGD:1313972 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of PSMD2 mRNA CTD PMID:31806706 nefazodone increases expression EXP 6480464 nefazodone results in increased expression of PSMD2 mRNA CTD PMID:24136188 nimesulide increases expression EXP 6480464 nimesulide results in increased expression of PSMD2 mRNA CTD PMID:24136188 patulin multiple interactions ISO RGD:1313973 6480464 NFE2L1 protein affects the reaction [Patulin results in increased expression of PSMD2 mRNA] CTD PMID:35367319 patulin increases expression ISO RGD:1313973 6480464 Patulin results in increased expression of PSMD2 mRNA CTD PMID:35367319 perfluorooctane-1-sulfonic acid affects expression ISO RGD:1313973 6480464 perfluorooctane sulfonic acid affects the expression of PSMD2 mRNA CTD PMID:19429403 perfluorooctane-1-sulfonic acid increases expression ISO RGD:1313973 6480464 perfluorooctane sulfonic acid results in increased expression of PSMD2 mRNA CTD PMID:20936131 perfluorooctanoic acid affects expression ISO RGD:1313973 6480464 perfluorooctanoic acid affects the expression of PSMD2 mRNA CTD PMID:19429403 perfluorooctanoic acid increases expression ISO RGD:1313972 6480464 perfluorooctanoic acid results in increased expression of PSMD2 protein CTD PMID:22609092 picoxystrobin decreases expression ISO RGD:1313972 6480464 picoxystrobin results in decreased expression of PSMD2 mRNA CTD PMID:33512557 piperonyl butoxide increases expression EXP 6480464 Piperonyl Butoxide results in increased expression of PSMD2 mRNA CTD PMID:22484513 pirinixic acid increases expression ISO RGD:1313973 6480464 pirinixic acid results in increased expression of PSMD2 mRNA CTD PMID:23811191 pregnenolone 16alpha-carbonitrile increases expression EXP 6480464 Pregnenolone Carbonitrile results in increased expression of PSMD2 mRNA CTD PMID:19162173 , PMID:21318169 Propiverine affects binding EXP 6480464 propiverine binds to PSMD2 protein CTD PMID:29273565 quercetin increases expression ISO RGD:1313972 6480464 Quercetin results in increased expression of PSMD2 mRNA CTD PMID:21632981 rac-lactic acid decreases expression ISO RGD:1313972 6480464 Lactic Acid results in decreased expression of PSMD2 mRNA CTD PMID:30851411 rotenone decreases expression ISO RGD:1313972 6480464 Rotenone results in decreased expression of PSMD2 mRNA CTD PMID:33512557 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of PSMD2 protein CTD PMID:35544339 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of PSMD2 protein CTD PMID:29459688 sodium arsenite increases expression ISO RGD:1313972 6480464 sodium arsenite results in increased expression of PSMD2 mRNA CTD PMID:34032870 sodium dichromate decreases expression ISO RGD:1313973 6480464 sodium bichromate results in decreased expression of PSMD2 mRNA CTD PMID:31558096 Tanshinone I increases expression ISO RGD:1313972 6480464 tanshinone results in increased expression of PSMD2 mRNA CTD PMID:15849732 trichloroethene affects expression ISO RGD:1313973 6480464 Trichloroethylene affects the expression of PSMD2 mRNA CTD PMID:21135412 trimellitic anhydride increases expression ISO RGD:1313973 6480464 trimellitic anhydride results in increased expression of PSMD2 mRNA CTD PMID:19042947 valdecoxib increases expression EXP 6480464 valdecoxib results in increased expression of PSMD2 mRNA CTD PMID:24136188 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of PSMD2 mRNA CTD PMID:21318169 valproic acid increases expression ISO RGD:1313972 6480464 Valproic Acid results in increased expression of PSMD2 mRNA CTD PMID:23179753 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of PSMD2 mRNA CTD PMID:23034163 vitamin E increases expression ISO RGD:1313972 6480464 Vitamin E results in increased expression of PSMD2 mRNA CTD PMID:19244175